JP7240097B2 - 屈折異常に対する素因を予測するための方法および試薬 - Google Patents

屈折異常に対する素因を予測するための方法および試薬 Download PDF

Info

Publication number
JP7240097B2
JP7240097B2 JP2017545686A JP2017545686A JP7240097B2 JP 7240097 B2 JP7240097 B2 JP 7240097B2 JP 2017545686 A JP2017545686 A JP 2017545686A JP 2017545686 A JP2017545686 A JP 2017545686A JP 7240097 B2 JP7240097 B2 JP 7240097B2
Authority
JP
Japan
Prior art keywords
exon
opsin gene
opsin
mrna
primer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2017545686A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018512121A (ja
JP2018512121A5 (https=
Inventor
ネイツ，ジェイ
ネイツ，モーリーン
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Washington
Original Assignee
University of Washington
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Washington filed Critical University of Washington
Publication of JP2018512121A publication Critical patent/JP2018512121A/ja
Publication of JP2018512121A5 publication Critical patent/JP2018512121A5/ja
Application granted granted Critical
Publication of JP7240097B2 publication Critical patent/JP7240097B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medical Informatics (AREA)
  • Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Plant Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
JP2017545686A 2015-02-27 2016-02-29 屈折異常に対する素因を予測するための方法および試薬 Active JP7240097B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562126284P 2015-02-27 2015-02-27
US62/126,284 2015-02-27
PCT/US2016/020033 WO2016138512A1 (en) 2015-02-27 2016-02-29 Methods and reagents for predicting predisposition to refractive error

Publications (3)

Publication Number Publication Date
JP2018512121A JP2018512121A (ja) 2018-05-17
JP2018512121A5 JP2018512121A5 (https=) 2020-02-27
JP7240097B2 true JP7240097B2 (ja) 2023-03-15

Family

ID=56789879

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017545686A Active JP7240097B2 (ja) 2015-02-27 2016-02-29 屈折異常に対する素因を予測するための方法および試薬

Country Status (9)

Country Link
US (1) US10787707B2 (https=)
EP (1) EP3261525B1 (https=)
JP (1) JP7240097B2 (https=)
KR (1) KR102551638B1 (https=)
CN (1) CN107529987B (https=)
AU (1) AU2016225033B2 (https=)
CA (1) CA2977808A1 (https=)
SG (2) SG11201706933TA (https=)
WO (1) WO2016138512A1 (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3491456B1 (en) 2016-08-01 2025-06-18 The University of Washington Ophthalmic lenses for treating myopia
EP4696489A2 (en) 2017-05-08 2026-02-18 SIGHTGLASS VISION, Inc. Methods for making contact lenses for reducing myopia
US10884264B2 (en) 2018-01-30 2021-01-05 Sightglass Vision, Inc. Ophthalmic lenses with light scattering for treating myopia
CA3200410A1 (en) 2018-07-12 2020-01-16 Sightglass Vision, Inc. Methods and devices for reducing myopia in children
EP3931626B1 (en) 2019-03-01 2026-02-25 Sightglass Vision, Inc. Ophthalmic lenses for reducing myopic progression and methods of making the same
EP3958789A4 (en) 2019-04-23 2022-09-28 Sightglass Vision, Inc. LENSES WITH DYNAMIC OPTICAL PROPERTIES TO REDUCE THE DEVELOPMENT OF MYOPIA

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009502119A (ja) 2005-06-23 2009-01-29 ユニヴェルスィタ’デッリ ストゥディ ディ ローマ ”トル ヴェルガータ” Ｌｏｘ−１タンパク質をコードする遺伝子の選択的スプライシングアイソフォーム、及びその使用
WO2012116248A1 (en) 2011-02-24 2012-08-30 Massachusetts Institute Of Technology ALTERNATIVELY SPLICED mRNA ISOFORMS AS PROGNOSTIC INDICATORS FOR METASTATIC CANCER
JP2014504873A (ja) 2011-01-14 2014-02-27 ザ ユニバーシティ オブ ワシントン スルー イッツ センター フォー コマーシャライゼーション 眼軸長関連障害を診断および治療する方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5800992A (en) 1989-06-07 1998-09-01 Fodor; Stephen P.A. Method of detecting nucleic acids
US6582908B2 (en) 1990-12-06 2003-06-24 Affymetrix, Inc. Oligonucleotides
US6706867B1 (en) 2000-12-19 2004-03-16 The United States Of America As Represented By The Department Of Health And Human Services DNA array sequence selection
EP1256632A3 (en) 2001-05-07 2004-01-02 Smithkline Beecham Corporation High throughput polymorphism screening
US20040110179A1 (en) 2002-03-15 2004-06-10 Shuber Anthony P. Method for alteration detection
DE60300792T2 (de) 2002-05-09 2005-12-01 Matsushita Electric Industrial Co., Ltd., Kadoma Inline-Elektronenkanone und Farbbildröhre mit selbiger
US20050208555A1 (en) 2004-03-16 2005-09-22 Affymetrix, Inc. Methods of genotyping
US7906289B2 (en) 2008-07-28 2011-03-15 Kaohsiung Medical University Using genetic polymorphisms of the BICD1 gene as a method for diagnosing and treating myopia
RU2011130572A (ru) 2008-12-22 2013-01-27 Дзе Медикал Колледж Оф Висконсин, Инк. Способ и устройство для ограничения роста длины глаза
WO2011034947A2 (en) * 2009-09-15 2011-03-24 University Of Washington Reagents and methods for modulating cone photoreceptor activity
JP5901046B2 (ja) * 2010-02-19 2016-04-06 国立大学法人 千葉大学 ＯＡＴＰ１Ｂ３ｍＲＮＡの新規な選択的スプライシングバリアント

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009502119A (ja) 2005-06-23 2009-01-29 ユニヴェルスィタ’デッリ ストゥディ ディ ローマ ”トル ヴェルガータ” Ｌｏｘ−１タンパク質をコードする遺伝子の選択的スプライシングアイソフォーム、及びその使用
JP2014504873A (ja) 2011-01-14 2014-02-27 ザ ユニバーシティ オブ ワシントン スルー イッツ センター フォー コマーシャライゼーション 眼軸長関連障害を診断および治療する方法
WO2012116248A1 (en) 2011-02-24 2012-08-30 Massachusetts Institute Of Technology ALTERNATIVELY SPLICED mRNA ISOFORMS AS PROGNOSTIC INDICATORS FOR METASTATIC CANCER

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
Ｂｉｏｃｈｅｍ．Ｂｉｏｐｈｙｓ．Ｒｅｓ．Ｃｏｍｍｕｎ．（２０１２）Ｖｏｌ．４２４，Ｎｏ．１，ｐ．１５２－１５７
Ｈｕｍ．Ｍｕｔａｔ．（２０１４）Ｖｏｌ．３５，Ｎｏ．１１，ｐ．１３５４－１３６２
Ｈｕｍａｎ ＤＮＡ ｓｅｑｕｅｎｃｅ ｆｒｏｍ ｃｌｏｎｅ ＸＸ－ＱＣ８Ｂ６ ｏｎ ｃｈｒｏｍｏｓｏｍｅ Ｘ Ｃｏｎｔａｉｎｓ ｔｈｅ ＯＰＮ１ＬＷ ｇｅｎｅ ｆｏｒ ｏｐｓｉｎ １ （ｃｏｎｅ ｐｉｇｍｅｎｔｓ）， ｌｏｎｇ－ｗａｖｅ－ｓｅｎｓｉｔｉｖｅ （ｃｏｌｏｒ ｂｌｉｎｄｎｅｓｓ， ｐｒｏｔａｎ） ａｎｄ ｔｈｅ ３’ ｅｎｄ ｏｆ ｔｈｅ ＣＸｏｒｆ２Ｂ ｇｅｎｅ ｆｏｒ ｃｈｒｏｍｏｓｏｍｅ Ｘ ｏｐｅｎ ｒｅａｄｉｎｇ ｆｒａｍｅ ２Ｂ， ｃｏｍｐｌｅｔｅ ｓｅｑｕｅｎｃｅ，［ｏｎｌｉｎｅ］，ＧｅｎＢａｎｋ，２００９年１月１５日，Ａｃｃｅｓｓｉｏｎ Ｎｏ： Ｚ６８１９３，［検索日］令和４年５月１７日，ＵＲＬ，ｈｔｔｐｓ：／／ｗｗｗ．ｎｃｂｉ．ｎｌｍ．ｎｉｈ．ｇｏｖ／ｎｕｃｃｏｒｅ／１１２２２８３？ｓａｔ＝１８＆ｓａｔｋｅｙ＝２８４２０８９７
Ｉｎｖｅｓｔ．Ｏｐｈｔｈａｌｍｏｌ．Ｖｉｓ．Ｓｃｉ．（２０１３）Ｖｏｌ．５４，Ｎｏ．２，ｐ．１３６１－１３６９

Also Published As

Publication number Publication date
HK1248498A1 (zh) 2018-10-19
EP3261525A4 (en) 2018-07-18
CN107529987B (zh) 2021-04-20
WO2016138512A1 (en) 2016-09-01
US20180112268A1 (en) 2018-04-26
CA2977808A1 (en) 2016-09-01
AU2016225033A1 (en) 2017-10-12
SG11201706933TA (en) 2017-09-28
EP3261525B1 (en) 2021-09-29
JP2018512121A (ja) 2018-05-17
EP3261525A1 (en) 2018-01-03
AU2016225033B2 (en) 2021-11-11
SG10202102575SA (en) 2021-04-29
KR20170122212A (ko) 2017-11-03
US10787707B2 (en) 2020-09-29
CN107529987A (zh) 2018-01-02
KR102551638B1 (ko) 2023-07-05

Similar Documents

Publication Publication Date Title
JP7240097B2 (ja) 屈折異常に対する素因を予測するための方法および試薬
Hansen et al. Genetic heterogeneity in microcornea-cataract: five novel mutations in CRYAA, CRYGD, and GJA8
Xu et al. Association of CFH, LOC387715, and HTRA1 polymorphisms with exudative age-related macular degeneration in a northern Chinese population
Willoughby et al. Defining the pathogenicity of optineurin in juvenile open-angle glaucoma
Han et al. Association of PAX6 polymorphisms with high myopia in Han Chinese nuclear families
Annamaneni et al. Association of vitamin D receptor gene start codon (Fok1) polymorphism with high myopia
Liu et al. Low prevalence of myocilin mutations in an African American population with primary open-angle glaucoma
CN106282197B (zh) 一种遗传性视网膜色素变性疾病的致病突变及其检测试剂
Zhang et al. Mutational screening of 10 genes in Chinese patients with microphthalmia and/or coloboma
Wang et al. ABCA4 deep intronic variants contributed to nearly half of unsolved Stargardt cases with a milder phenotype
Kelberman et al. CYP1B1-Related anterior segment developmental anomalies: novel mutations for infantile glaucoma and Von Hippel's ulcer revisited
CN107312859A (zh) Aqp5基因在制备检测先天性白内障制品中的应用
HK1248498B (en) Methods and reagents for predicting predisposition to refractive error
Zhang et al. Clinical and genetic analysis VSX1 variants among families with keratoconus in northwest China
CN115851918B (zh) 一种导致视网膜营养不良的致病基因cfap410突变位点的应用及检测试剂
CN103820548B (zh) Myo18a基因在制备先天性小眼球诊断制品中的应用
JP6998476B2 (ja) 近視の発症リスクを判定する方法
US20070117095A1 (en) Diagnostic method for neonatal or infantile epilepsy syndromes
Tonska Agnieszka Piotrowska-Nowak, Ewa Kosior-Jarecka b, Aleksandra Schab, Dominika Wrobel-Dudzinska b, Ewa Bartnik, Tomasz Zarnowski b, Katarzyna Tonska
Pham et al. The CYP4F2* 3 variant polymorphism and risk factors for stroke at Thai Nguyen national hospital
CN115851898A (zh) 一种bpes综合征致病基因foxl2突变位点的应用及其诊断试剂
KR100443503B1 (ko) 가족성 고콜레스테롤혈증을 유발하는 인간 저밀도 지단백질 수용체 유전자의 돌연변이체, 이의 검출 방법 및 이 방법에 유용한 프라이머
CN117821580A (zh) Fktn基因突变体、突变体蛋白、试剂、试剂盒及应用
den Hollander PhD 4.5. Variants in the PRPF8 gene are associated with glaucoma.
EP2478115A1 (en) Method for the diagnosis of limbal stem cell deficiency

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20170825

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20190121

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20191004

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20191016

A524 Written submission of copy of amendment under article 19 pct

Free format text: JAPANESE INTERMEDIATE CODE: A524

Effective date: 20200116

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20200701

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20201030

C60 Trial request (containing other claim documents, opposition documents)

Free format text: JAPANESE INTERMEDIATE CODE: C60

Effective date: 20201030

C11 Written invitation by the commissioner to file amendments

Free format text: JAPANESE INTERMEDIATE CODE: C11

Effective date: 20201110

A911 Transfer to examiner for re-examination before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20201214

C21 Notice of transfer of a case for reconsideration by examiners before appeal proceedings

Free format text: JAPANESE INTERMEDIATE CODE: C21

Effective date: 20201215

A912 Re-examination (zenchi) completed and case transferred to appeal board

Free format text: JAPANESE INTERMEDIATE CODE: A912

Effective date: 20210212

C211 Notice of termination of reconsideration by examiners before appeal proceedings

Free format text: JAPANESE INTERMEDIATE CODE: C211

Effective date: 20210216

C22 Notice of designation (change) of administrative judge

Free format text: JAPANESE INTERMEDIATE CODE: C22

Effective date: 20210702

C22 Notice of designation (change) of administrative judge

Free format text: JAPANESE INTERMEDIATE CODE: C22

Effective date: 20220118

C22 Notice of designation (change) of administrative judge

Free format text: JAPANESE INTERMEDIATE CODE: C22

Effective date: 20220407

C13 Notice of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: C13

Effective date: 20220601

C28A Non-patent document cited

Free format text: JAPANESE INTERMEDIATE CODE: C2838

Effective date: 20220601

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20220826

C22 Notice of designation (change) of administrative judge

Free format text: JAPANESE INTERMEDIATE CODE: C22

Effective date: 20230105

C23 Notice of termination of proceedings

Free format text: JAPANESE INTERMEDIATE CODE: C23

Effective date: 20230111

C03 Trial/appeal decision taken

Free format text: JAPANESE INTERMEDIATE CODE: C03

Effective date: 20230203

C30A Notification sent

Free format text: JAPANESE INTERMEDIATE CODE: C3012

Effective date: 20230203

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20230303

R150 Certificate of patent or registration of utility model

Ref document number: 7240097

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150